Novavax Receives Conditional-Marketing Authorization in Europe

https://www.prnewswire.com/news-releases/novavax-receives-positive-european-medicines-agency-recommendation-for-conditional-marketing-authorization-of-its-covid-19-vaccine-301448175.html As seen on the PR News Wire Monday, December 20, 2021: Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,…

Continue ReadingNovavax Receives Conditional-Marketing Authorization in Europe